This is a synthetic peptide designed for use in combination with anti-LSM5 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
LSM5
(LSM5 Homolog, U6 Small Nuclear RNA Associated (LSM5))
Synonyme
K24G6.21 Peptide, K24G6_21 Peptide, SUPERSENSITIVE TO ABA AND DROUGHT 1 Peptide, An13g00820 Peptide, YER146W Peptide, 2010208O10Rik Peptide, 2310034K10Rik Peptide, LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated Peptide, LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated L homeolog Peptide, Small nuclear ribonucleoprotein family protein Peptide, U6 snRNA-associated Sm-like protein LSm5 Peptide, Lsm5 Peptide, LSM5 Peptide, lsm5.L Peptide, SAD1 Peptide, ANI_1_116114 Peptide, PVX_118325 Peptide, SS1G_05691 Peptide, Bm1_50275 Peptide, Bm1_50295 Peptide, AOR_1_212174 Peptide, lsm5 Peptide
Hintergrund
Sm-like proteins were identified in a variety of organisms based on sequence homology with the Sm protein family (see SNRPD2, MIM 601061). Sm-like proteins contain the Sm sequence motif, which consists of 2 regions separated by a linker of variable length that folds as a loop. The Sm-like proteins are thought to form a stable heteromer present in tri-snRNP particles, which are important for pre-mRNA splicing.